Back
Cytokinetics, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
CYTK
Cytokinetics, Inc.
Last Price:
$59.76
Seasonality Move:
9.8%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCytokinetics, Inc. Stock Forecast
-
Over the next 52 weeks, Cytokinetics, Inc. has on average historically risen by 11.7% based on the past 21 years of stock performance.
-
Cytokinetics, Inc. has risen higher in 8 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.1%
-
Is Cytokinetics, Inc. Stock Undervalued?The current Cytokinetics, Inc. [CYTK] share price is $59.82. The Score for CYTK is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
CYTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cytokinetics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cytokinetics, Inc. has on average historically risen by 11.7% based on the past 21 years of stock performance.
Cytokinetics, Inc. Stock Rating
Sell
35
Cytokinetics, Inc. (CYTK)
is a Sell
Is Cytokinetics, Inc. overpriced?
-
Cytokinetics, Inc. has risen higher in 8 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.1%
Cytokinetics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com
52-Week Data
52-Week High:
69.33
52-Week Low:
29.31
Prediction Charts
Market Cap:
7.3B
Price in USD:
59.82
Volume:
2M
Beta:
1.44
Technical Analysis
SMA50:
62.47
SMA100:
53.54
SMA200:
45.20
52-Wk Change:
25.2%
Stock Predictions
-
Is Cytokinetics, Inc. stock public?Yes, Cytokinetics, Inc. is a publicly traded company.
-
What is the Cytokinetics, Inc. stock quote today?The Cytokinetics, Inc. stock price is 59.82 USD today.
-
How to buy Cytokinetics, Inc. stock online?You can buy Cytokinetics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 68.60 | 68.13 | 69.33 | 67.71 |
| Dec-1 | 67.89 | 66.05 | 67.99 | 65.92 |
| Dec-2 | 65.85 | 63.51 | 65.85 | 62.58 |
| Dec-3 | 63.69 | 64.66 | 65.51 | 63.59 |
| Dec-4 | 64.06 | 66.54 | 67.26 | 63.50 |
| Dec-5 | 66.49 | 65.67 | 66.95 | 65.36 |
| Dec-8 | 65.88 | 64.13 | 66.37 | 63.63 |
| Dec-9 | 64.41 | 61.60 | 65.46 | 61.31 |
| Dec-10 | 61.56 | 60.32 | 62.27 | 59.71 |
| Dec-11 | 60.41 | 60.77 | 60.99 | 59.56 |
| Dec-12 | 60.99 | 63.35 | 63.80 | 60.45 |
| Dec-15 | 63.45 | 62.16 | 64.12 | 62.00 |
| Dec-16 | 61.98 | 62.02 | 62.36 | 60.43 |
| Dec-17 | 62.10 | 59.82 | 62.26 | 59.37 |
Cytokinetics, Inc. Earnings
Cytokinetics, Inc. Earnings Report: Per Share Cytokinetics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cytokinetics, Inc. Forecast Revenue Growth
Cytokinetics, Inc. Stock Analysis: Historical quarterly revenues per share for Cytokinetics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and an increase next year of $0.15 per share.
* Cytokinetics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.